From models to people

Cells, animals and people allow researchers to ask different questions. A model can reveal a mechanism without demonstrating a clinical benefit. A human study can also leave important questions open if its population, comparison or outcome does not match the claim. Read each result as a sentence with an exact material, a studied setting and a measured change. [1] [2]

What you will learn

Match a research claim to the model, population and outcome needed to test it.
Distinguish a clinical outcome from a biomarker or proposed surrogate.
Write a study summary that includes the comparator and the most consequential limit.

Start by matching the question

A cell experiment can isolate part of a biological process. An animal model can connect processes across a living organism, but the species, condition and measured outcome still matter. A human trial asks a question in its enrolled population. These settings form connections in research, rather than automatic upgrades in which every later claim inherits every earlier result. [1] [3]

For example, a GHK-Cu study reported connective-tissue accumulation in a rat wound-chamber model. That statement tells you the material, species and measured change. Replacing it with “improves recovery” drops the defining information and adds a broader conclusion. A useful summary should let the reader reconstruct the original question before considering what it might mean for another setting. [4]

Read the model description

The ARRIVE reporting guidance identifies information needed to judge animal research, including the species and animal characteristics, groups, sample-size basis, exclusions, randomization, blinding and outcome measures. For a reader, these details explain what observations were made and how bias was addressed. They are not a score that makes every well-described model directly predictive of human outcomes. [1]

An experiment's independent units also matter. Several measurements from one animal do not necessarily represent several independent animals. The report should make the unit of analysis clear. When a record's sample size is unknown, keep it unknown. Do not convert the number of measurements, images or samples into a participant count unless the source establishes that relationship. [5]

Human research needs its own context

In a randomized trial, participants are allocated to groups to support a fair comparison. The comparison might be placebo or an active treatment. Eligibility criteria, follow-up, missing data and the analysis plan shape how the results should be understood. CONSORT reporting guidance also asks how harms were assessed. “A human trial exists” is therefore the beginning of inspection, rather than a complete verdict. [2]

A result applies first to the studied material, population, comparator and outcome. A trial in a specific disease population cannot automatically answer a question in healthy people. Two papers from one cohort may examine different outcomes without representing two independent trials. Use publication records to find the detail, and track the shared trial or cohort when deciding how much distinct evidence you have. [2] [3]

Read the measurement before the claim

A clinical outcome can describe how people feel, function or survive. A biomarker is a measured indicator of a biological process or response. Some biomarkers can serve as surrogate endpoints when sufficient evidence supports their relationship to clinical benefit in the relevant setting. That relationship needs evidence; it does not appear merely because the marker changed in a favorable-looking direction. [6]

A change in signaling, hormone concentration or collagen content may help explain biology. To judge a broader claim, ask what connects that measurement to the outcome being claimed. FDA's explanation of surrogate endpoints emphasizes context of use. A validated surrogate for one purpose is not blanket permission to treat every laboratory marker or every population as interchangeable. [6]

Use this when reading a paper

Write a short note with five parts: the exact material; who or what was studied; the comparator; the outcome; and the main limit. If an abstract does not supply one part, leave it visible as missing. A source link gives you somewhere to investigate. It does not turn missing methods into known methods or a mechanistic observation into a clinical endpoint. [1] [2] [6]

Finally, keep “no clear difference established,” “not measured,” and “not reported in the accessible source” distinct. They describe different situations. A sparse record may justify a narrower summary and another reading question. That is still useful: you can explain what the paper contributes while keeping the unanswered connection beside the finding. [2] [1] [3]

Common questions

Are animal studies useless for human questions? No. They can test biological ideas. The step to a human outcome requires evidence relevant to the material, population and question. [3] [1]

Does a positive human study settle every use? No. Read its eligibility criteria, comparator, endpoint, follow-up and harms before extending the result. [3]

Is an unreported harm the same as no harm? No. The report must describe how harms were assessed. Missing reporting cannot establish that nothing occurred. [2]

Worked example: trace the missing step in a recovery claim

Suppose a claim says that a peptide “restores function after injury.” You find three imagined reports: cells moved faster in a dish; an animal tissue contained more collagen; and people had a change in a blood marker. These reports are invented for this exercise, not descriptions of a specific peptide’s record. Each measures something that may interest researchers, but none has yet measured the claimed functional recovery. [6]

To answer the claim in people, first define function concretely: for example, ability to walk or perform a specified task after a specified injury. Then look for a suitable human study with the identified material, an informative comparator and follow-up appropriate to that outcome. If the study measures only a marker, ask what evidence connects that marker to function in this particular setting. [6] [2]

The earlier experiments can help explain a hypothesis and guide further research. A faithful conclusion states what each observed and identifies the unmeasured connection. A larger stack of mechanistic papers does not turn an outcome that was never measured into an observed human result. [1] [2]

Check your understanding

A blood marker changes in people, but walking ability was never measured. What can a summary say about recovery of walking?

Show explanation

It can describe the marker change and explain that walking ability was not measured. A claim about walking needs a relevant clinical outcome or evidence supporting a suitable surrogate in that context. [6]

Two articles report different outcomes from the same trial. Are they automatically two independent trials?